Roivant Sciences (ROIV) Minority Interest (2021 - 2026)

Roivant Sciences has reported Minority Interest for 6 years, with the latest figure at $765.0 million in Q1 2026.

• For the quarter ending Q1 2026, Minority Interest rose 53.13% year-over-year to $765.0 million; the trailing twelve-month figure through Mar 2026 stood at $765.0 million (up 53.13% YoY), and the FY2026 full-year result was $765.0 million, up 53.13% from the prior year.
• Minority Interest for Q1 2026 stood at $765.0 million, up from $705.0 million in the prior quarter.
• The five-year high for Minority Interest was $765.0 million in Q1 2026, with the low at $22.5 million in Q1 2022.
• Historically, Minority Interest has averaged $444.7 million across 5 years, with a median of $449.8 million in 2023.
• Annual changes were most pronounced in 2022 — Minority Interest slumped 90.7% — and 2023, when it jumped 1900.0%.
• Roivant Sciences' Minority Interest stood at $471.6 million in 2022, then rose by 4.92% to $494.8 million in 2023, then decreased by 29.97% to $346.5 million in 2024, then jumped by 103.46% to $705.0 million in 2025, then gained by 8.52% to $765.0 million in 2026.
• The last three Minority Interest figures came in at $765.0 million (Q1 2026), $705.0 million (Q4 2025), and $443.1 million (Q3 2025), per Business Quant data.